Prot #1438-0007: DAREON™-7: A Phase I, Open-Label, Dose Escalation and Expansion Trial to Investigate Safety and Tolerability of BI 764532 Intravenous Infusions in Combination with Standard of Care (Platinum and Etoposide) in First-Line Treatment of Patie

Project: Research project

Project Details

StatusActive
Effective start/end date3/16/24 → 3/16/27

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1438-0007)